{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:41:19Z","timestamp":1790606479106,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH T32 Geriatric Oncology Training Grant","award":["5T32CA233419-04"],"award-info":[{"award-number":["5T32CA233419-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"DOI":"10.1038\/s41514-025-00320-2","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:27:54Z","timestamp":1772720874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cancer incidence and mortality trends among older adults"],"prefix":"10.1038","volume":"12","author":[{"given":"Ryan T.","family":"Morse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyman B.","family":"Muss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam A.","family":"VanderWalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"320_CR1","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","volume":"27","author":"BD Smith","year":"2009","unstructured":"Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N. & Buchholz, T. A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 27, 2758\u20132765 (2009).","journal-title":"J. Clin. Oncol."},{"key":"320_CR2","doi-asserted-by":"publisher","unstructured":"Garner, W. B. et al. Predicting future cancer incidence by age, race, ethnicity, and sex. J. Geriatric Oncol. 2022\/10\/28\/; https:\/\/doi.org\/10.1016\/j.jgo.2022.10.008 (2022)","DOI":"10.1016\/j.jgo.2022.10.008"},{"key":"320_CR3","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.21.00317","volume":"39","author":"SM Lichtman","year":"2021","unstructured":"Lichtman, S. M., Cohen, H. J., Muss, H., Tew, W. P. & Korc-Grodzicki, B. From Assessment to Implementation and Beyond in Cancer and Aging Research. J. Clin. Oncol. 39, 2217\u20132225 (2021).","journal-title":"J. Clin. Oncol."},{"key":"320_CR4","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1056\/NEJMp2106089","volume":"385","author":"MM Bertagnolli","year":"2021","unstructured":"Bertagnolli, M. M. & Singh, H. Treatment of older adults with cancer - addressing gaps in evidence. N. Engl. J. Med 385, 1062\u20131065 (2021).","journal-title":"N. Engl. J. Med"},{"key":"320_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jgo.2021.07.008","volume":"13","author":"NA VanderWalde","year":"2022","unstructured":"VanderWalde, N. A. et al. Disparities in older adult accrual to cancer trials: analysis from the alliance for clinical trials in oncology (A151736). J. Geriatr. Oncol. 13, 20\u201326 (2022).","journal-title":"J. Geriatr. Oncol."},{"key":"320_CR6","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jamaoncol.2019.2055","volume":"5","author":"EB Ludmir","year":"2019","unstructured":"Ludmir, E. B. et al. Factors associated with age disparities among cancer clinical trial participants. JAMA Oncol. 5, 1769\u20131773 (2019).","journal-title":"JAMA Oncol."},{"key":"320_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1200\/OP.20.00442","volume":"17","author":"W Dale","year":"2021","unstructured":"Dale, W. et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol. Pract. 17, 336\u2013344 (2021).","journal-title":"JCO Oncol. Pract."},{"key":"320_CR8","doi-asserted-by":"publisher","first-page":"101393","DOI":"10.1016\/j.jgo.2022.10.008","volume":"14","author":"WB Garner","year":"2023","unstructured":"Garner, W. B. et al. Predicting future cancer incidence by age, race, ethnicity, and sex. J. Geriatr. Oncol. 14, 101393 (2023).","journal-title":"J. Geriatr. Oncol."},{"key":"320_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","volume":"25","author":"SM Bluethmann","year":"2016","unstructured":"Bluethmann, S. M., Mariotto, A. B. & Rowland, J. H. Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol. Biomark. Prev. 25, 1029\u20131036 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"320_CR10","first-page":"452","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis, C. E. et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J. Clin. 69, 452\u2013467 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"320_CR11","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/annonc\/mdz178","volume":"30","author":"G Carioli","year":"2019","unstructured":"Carioli, G. et al. Cancer mortality in the elderly in 11 countries worldwide, 1970-2015. Ann. Oncol. 30, 1344\u20131355 (2019).","journal-title":"Ann. Oncol."},{"key":"320_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/cncr.26376","volume":"118","author":"C Harding","year":"2012","unstructured":"Harding, C., Pompei, F. & Wilson, R. Peak and decline in cancer incidence, mortality, and prevalence at old ages. Cancer 118, 1371\u20131386 (2012).","journal-title":"Cancer"},{"key":"320_CR13","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib, L., Wehner, M. R., Matrisian, L. M. & Nead, K. T. Estimated projection of US cancer incidence and death to 2040. JAMA Netw. Open 4, e214708 (2021).","journal-title":"JAMA Netw. Open"},{"key":"320_CR14","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"320_CR15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/jncimonographs\/lgs035","volume":"2012","author":"OW Brawley","year":"2012","unstructured":"Brawley, O. W. Trends in prostate cancer in the United States. J. Natl. Cancer Inst. Monogr. 2012, 152\u2013156 (2012).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"320_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1001\/jama.2015.14905","volume":"314","author":"A Jemal","year":"2015","unstructured":"Jemal, A. et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. Jama 314, 2054\u20132061 (2015).","journal-title":"Jama"},{"key":"320_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer, V. A. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 157, 120\u2013134 (2012).","journal-title":"Ann. Intern. Med."},{"key":"320_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","volume":"164","author":"HD Nelson","year":"2016","unstructured":"Nelson, H. D. et al. Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann. Intern. Med. 164, 244\u2013255 (2016).","journal-title":"Ann. Intern. Med."},{"key":"320_CR19","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"DA Berry","year":"2005","unstructured":"Berry, D. A. et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 353, 1784\u20131792 (2005).","journal-title":"N. Engl. J. Med."},{"key":"320_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJMsb2019760","volume":"384","author":"HG Welch","year":"2021","unstructured":"Welch, H. G., Mazer, B. L. & Adamson, A. S. The rapid rise in cutaneous melanoma diagnoses. N. Engl. J. Med. 384, 72\u201379 (2021).","journal-title":"N. Engl. J. Med."},{"key":"320_CR21","doi-asserted-by":"publisher","first-page":"e212907","DOI":"10.1001\/jamaoncol.2021.2907","volume":"7","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Fakhry, C. & D\u2019Souza, G. Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045. JAMA Oncol. 7, e212907 (2021).","journal-title":"JAMA Oncol."},{"key":"320_CR22","doi-asserted-by":"publisher","unstructured":"Damgacioglu, H. et al. Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: a modeling study. Lancet Reg. Health Am. Dec 15: 100143. https:\/\/doi.org\/10.1016\/j.lana.2021.100143 (2021)","DOI":"10.1016\/j.lana.2021.100143"},{"key":"320_CR23","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"320_CR24","unstructured":"Cancer and obesity. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/vitalsigns\/obesity-cancer\/infographic.html#graphic. Published October 3, 2017. Accessed May 19, (CDC, 2023)."},{"key":"320_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395\u2013409 (2011). Aug 4.","journal-title":"N. Engl. J. Med."},{"key":"320_CR26","first-page":"84","volume":"74","author":"KK Kondo","year":"2024","unstructured":"Kondo, K. K. et al. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: a systematic review. CA Cancer J. Clin. 74, 84\u2013114 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"320_CR27","first-page":"50","volume":"74","author":"AMD Wolf","year":"2024","unstructured":"Wolf, A. M. D. et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J. Clin. 74, 50\u201381 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"320_CR28","first-page":"177","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L. et al. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67, 177\u2013193 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"320_CR29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","volume":"387","author":"M Bretthauer","year":"2022","unstructured":"Bretthauer, M. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N. Engl. J. Med. 387, 1547\u20131556 (2022).","journal-title":"N. Engl. J. Med."},{"key":"320_CR30","doi-asserted-by":"publisher","first-page":"i6673","DOI":"10.1136\/bmj.i6673","volume":"356","author":"\u00d8 Holme","year":"2017","unstructured":"Holme, \u00d8. et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ 356, i6673 (2017).","journal-title":"BMJ"},{"key":"320_CR31","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"KW Davidson","year":"2021","unstructured":"Davidson, K. W. et al. Screening for colorectal cancer: US preventive services task force recommendation statement. Jama 325, 1965\u20131977 (2021).","journal-title":"Jama"},{"key":"320_CR32","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179\u20132185 (2019).","journal-title":"Gut"},{"key":"320_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jncimonographs\/lgac021","volume":"2022","author":"A Magnuson","year":"2022","unstructured":"Magnuson, A. et al. Integrating geriatric assessment measures into national cancer institute clinical trials. J. Natl. Cancer Inst. Monogr. 2022, 142\u2013150 (2022).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"320_CR34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert, F. et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med. 356, 1527\u20131535 (2007).","journal-title":"N. Engl. J. Med."},{"key":"320_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry, J. R. et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N. Engl. J. Med. 376, 1027\u20131037 (2017).","journal-title":"N. Engl. J. Med."},{"key":"320_CR36","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","volume":"22","author":"W Roa","year":"2004","unstructured":"Roa, W. et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol. 22, 1583\u20131588 (2004).","journal-title":"J. Clin. Oncol."},{"key":"320_CR37","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","volume":"33","author":"W Roa","year":"2015","unstructured":"Roa, W. et al. International atomic energy agency randomized phase iii study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme. J. Clin. Oncol. 33, 4145\u20134150 (2015).","journal-title":"J. Clin. Oncol."},{"key":"320_CR38","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick, W. et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 13, 707\u2013715 (2012).","journal-title":"Lancet Oncol."},{"key":"320_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1200\/JCO.2015.65.0739","volume":"34","author":"R Carmona","year":"2016","unstructured":"Carmona, R. et al. Improved method to stratify elderly patients with cancer at risk for competing events. J. Clin. Oncol. 34, 1270\u20131277 (2016).","journal-title":"J. Clin. Oncol."},{"key":"320_CR40","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1200\/JCO.2010.30.2802","volume":"28","author":"LK Mell","year":"2010","unstructured":"Mell, L. K. & Jeong, J. H. Pitfalls of using composite primary end points in the presence of competing risks. J. Clin. Oncol. 28, 4297\u20134299 (2010).","journal-title":"J. Clin. Oncol."},{"key":"320_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jnci\/djy169","volume":"110","author":"LA Levit","year":"2018","unstructured":"Levit, L. A., Singh, H., Klepin, H. D. & Hurria, A. Expanding the evidence base in geriatric oncology: action items from an FDA-ASCO workshop. J. Natl. Cancer Inst. 110, 1163\u20131170 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"320_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jgo.2016.11.001","volume":"8","author":"H Singh","year":"2017","unstructured":"Singh, H., Beaver, J. A., Kim, G. & Pazdur, R. Enrollment of older adults on oncology trials: an FDA perspective. J. Geriatr. Oncol. 8, 149\u2013150 (2017).","journal-title":"J. Geriatr. Oncol."},{"key":"320_CR43","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile, S. G. et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J. Clin. Oncol. 36, 2326\u20132347 (2018).","journal-title":"J. Clin. Oncol."},{"key":"320_CR44","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li, D. et al. Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol. 7, e214158 (2021).","journal-title":"JAMA Oncol."},{"key":"320_CR45","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile, S. G. et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet 398, 1894\u20131904 (2021).","journal-title":"Lancet"},{"key":"320_CR46","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1200\/JCO.2020.38.15_suppl.12011","volume":"38","author":"W-K Soo","year":"2020","unstructured":"Soo, W.-K. et al. Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy. J. Clin. Oncol. 38, 12011\u201312011 (2020).","journal-title":"J. Clin. Oncol."},{"key":"320_CR47","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1200\/JCO.2016.67.5926","volume":"34","author":"A Gajra","year":"2016","unstructured":"Gajra, A. et al. Comprehensive geriatric assessment-guided therapy does improve outcomes of older patients with advanced lung cancer. J. Clin. Oncol. 34, 4047\u20134048 (2016).","journal-title":"J. Clin. Oncol."},{"key":"320_CR48","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1200\/JCO.2015.63.5839","volume":"34","author":"R Corre","year":"2016","unstructured":"Corre, R. et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08-02 study. J. Clin. Oncol. 34, 1476\u20131483 (2016).","journal-title":"J. Clin. Oncol."},{"key":"320_CR49","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria, A. et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J. Clin. Oncol. 29, 1290\u20131296 (2011).","journal-title":"J. Clin. Oncol."},{"key":"320_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jgo.2014.03.001","volume":"5","author":"GR Williams","year":"2014","unstructured":"Williams, G. R. et al. Feasibility of geriatric assessment in community oncology clinics. J. Geriatr. Oncol. 5, 245\u2013251 (2014).","journal-title":"J. Geriatr. Oncol."},{"key":"320_CR51","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/gerona\/gls233","volume":"68","author":"ME Levine","year":"2013","unstructured":"Levine, M. E. Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? J. Gerontol. A Biol. Sci. Med Sci. 68, 667\u2013674 (2013).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"320_CR52","doi-asserted-by":"publisher","unstructured":"Warren J. L., Klabunde C. N., Schrag D., Bach P. B., Riley G. F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 40, Iv-3-18. https:\/\/doi.org\/10.1097\/01.Mlr.0000020942.47004.03 (2002)","DOI":"10.1097\/01.Mlr.0000020942.47004.03"},{"key":"320_CR53","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 8.4.0.1."},{"key":"320_CR54","unstructured":"National Cancer Institute. Overview of the SEER Program. Accessed Novemebr 15, https:\/\/seer.cancer.gov\/about\/overview.html. (NCI, 2022)"},{"key":"320_CR55","doi-asserted-by":"publisher","first-page":"e2027738","DOI":"10.1001\/jamanetworkopen.2020.27738","volume":"3","author":"AR Scott","year":"2020","unstructured":"Scott, A. R. et al. Trends in cancer incidence in US adolescents and young adults, 1973-2015. JAMA Netw. Open 3, e2027738 (2020).","journal-title":"JAMA Netw. Open"},{"key":"320_CR56","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: incidence - SEER Research Plus Data, 8 Registries, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Total U.S., 1969-2020 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2022, based on the November 2021 submission."},{"key":"320_CR57","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: mortality - All COD, Aggregated With State, Total U.S. (1969-2019) <Katrina\/Rita Population Adjustment>, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2021. Underlying mortality data provided by NCHS (www.cdc.gov\/nchs)."},{"key":"320_CR58","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","volume":"36","author":"HS Park","year":"2012","unstructured":"Park, H. S., Lloyd, S., Decker, R. H., Wilson, L. D. & Yu, J. B. Overview of the surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance. Curr. Probl. Cancer 36, 183\u2013190 (2012).","journal-title":"Curr. Probl. Cancer"},{"key":"320_CR59","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41467-018-08170-1","volume":"10","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky, N. G. et al. Suicide among cancer patients. Nat. Commun. 10, 207 (2019).","journal-title":"Nat. Commun."},{"key":"320_CR60","unstructured":"Boer, R. et al. Ambiguities in calculating cancer patient survival: the SEER experience for colorectal and prostate cancer. Statistical Research and Applications Branch. (NCI, 2002)."},{"key":"320_CR61","unstructured":"National Cancer Institute. Casefinding studies\u2014SEER quality improvement. Published November 8, 2008. Accessed Novemebr 15, https:\/\/seer.cancer.gov\/qi\/tools\/casefinding.html. (NCI, 2022)"},{"key":"320_CR62","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim, H. J., Fay, M. P., Feuer, E. J. & Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med 19, 335\u2013351 (2000).","journal-title":"Stat. Med"}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00320-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:30:54Z","timestamp":1772771454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-025-00320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1038\/s41514-025-00320-2","relation":{},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}